Biologics or Hardware (mini metal) for Cartilage Lesions: When Too Young, When Too Old, When Too Active, When Too Sedentary?
Martin Lind, MD, PhD, Prof., DENMARK Roland Becker, MD, PhD, Prof., GERMANY Mats G. Brittberg, MD, PhD, Prof., SWEDEN Karl Eriksson, MD, PhD, Prof., SWEDEN Carola F. van Eck, MD, PhD, FAAOS, UNITED STATES Peter Verdonk, MD, PhD, BELGIUM
2021 Congress
Symposium
2021
group rating (17)
Recognize options for treatment in the patient group with symptomatic cartilage lesions in the knee that are in the "Gap age" of 35-60 year where biological treatment options have reduced success and the patients are considered to young for arthroplasty.